BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Medtronic Reports 2019 Third Quarter Financial Results

  Medtronic plc announced financial results for its third quarter of fiscal year 2019, which ended January 25, 2019.

  February 19, 2019

   · 

  13 min read
• FDA

  Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

  Medtronic plc, the global leader in medical technology, announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its Personalized Closed Loop insulin pump system, currently in development.

  February 19, 2019

   · 

  2 min read
• Business

  Ad hoc: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire

  Planegg/Munich, Germany, February 19, 2019 Simon Moroney, CEO and co-founder of MorphoSys AG, informed the Company’s Supervisory Board that he has decided not to renew his contract as a member of the company’s Management Board.

  February 19, 2019

   · 

  4 min read
• Business

  Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire

  Simon Moroney, CEO and co-founder of MorphoSys AG informed the Company’s Supervisory Board that he has decided not to renew his contract as a member of the company’s Management Board.

  February 19, 2019

   · 

  6 min read
• Deals

  ASIT biotech: 2019 Financial Calendar

  ASIT biotech, a Belgian biopharmaceutical company specialized in the research and development of innovative allergy immunotherapy products, announces its preliminary financial calendar for 2019.

  February 19, 2019

   · 

  1 min read
• 

  Business

  New Addition to AgriMetis® Scientific Advisory Board Enhances Powerhouse in Research & Development

  AgriMetis, LLC, is pleased to announce Dr. Adrian Percy joined the scientific advisory board (SAB) on February 1, 2019.

  February 19, 2019

   · 

  3 min read
• 

  Business

  Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update

  Strong Launch Continues With More than 550 Patients on Reimbursed Commercial Crysvita® (burosumab) Therapy in the United States at End of 4th Quarter 2018, 80 Percent Increase Versus End of 3rd Quarter

  February 19, 2019

   · 

  11 min read